Skip to content

Clinical trials

Terminated Breast Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: Australia Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20082
20092
20101
20121
20131
20154
20161
20174
20181
20194
20204
20212
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Pfizer4
Eli Lilly and Company2
Fusion Pharmaceuticals Inc.2
Jules Bordet Institute2
Odonate Therapeutics, Inc.2
AVEO Pharmaceuticals, Inc.1
AbbVie1
Actym Therapeutics, Inc.1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms37
Ovarian Neoplasms8
Colorectal Neoplasms5
Prostatic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis4
Neoplasms4
Pancreatic Neoplasms4
Stomach Neoplasms4
Urinary Bladder Neoplasms4

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.